 HYDERABAD, India--BUSINESS WIRE--Dr. Reddys Laboratories Limited BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as Dr. Reddys today announced that its Annual Report on Form 20-F containing its consolidated financial statements for the fiscal year ended March 31, 2021 and prepared in accordance with the International Financial Reporting Standards IFRS as issued by the International Accounting Standards Board was filed with the U 